Shield Therapeutics plc (STX.L)
GBp 2.75
(0.0%)
GBp 2.75
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 13.08 Million | 4.46 Million | 1.51 Million | 10.38 Million | 719 Thousand | 11.88 Million |
| Cost of Revenue | 9.05 Million | 2.47 Million | 980 Thousand | 1.35 Million | 485 Thousand | 311 Thousand |
| Gross Profit | 4.02 Million | 1.99 Million | 539 Thousand | 9.03 Million | 234 Thousand | 11.57 Million |
| Operating Expenses | 35.35 Million | 27.7 Million | 20.49 Million | 11.18 Million | 9.26 Million | 16.73 Million |
| Selling, General and Administrative Expenses | 36.88 Million | 27.33 Million | 20.02 Million | 5.9 Million | 4.15 Million | 10.08 Million |
| Research and Development Expenses | 1.81 Million | 1.07 Million | 579 Thousand | 2.57 Million | 2.49 Million | 4.3 Million |
| Other Expenses | -3.34 Million | -700 Thousand | -111 Thousand | 2.7 Million | 2.62 Million | 2.35 Million |
| Cost and Expenses | 44.41 Million | 30.17 Million | 21.47 Million | 12.54 Million | 9.75 Million | 17.04 Million |
| Operating Income | -31.33 Million | -25.7 Million | -19.95 Million | -1.88 Million | -9.03 Million | -5.16 Million |
| Interest Expense | 1.01 Million | 389 Thousand | 8000.00 | 1000.00 | 49 Thousand | 35 Thousand |
| Income Tax Expense | 918 Thousand | 362 Thousand | -229 Thousand | 744 Thousand | -266 Thousand | -3.35 Million |
| Earnings before Tax | -26.04 Million | -40.08 Million | -19.56 Million | -1.88 Million | -9.06 Million | -5.15 Million |
| Net Income | -33.29 Million | -40.44 Million | -19.33 Million | -2.63 Million | -8.8 Million | -1.79 Million |
| Earnings Per Share Basic | -0.05 | -0.17 | -0.09 | -0.02 | -0.07 | -0.02 |
| Earnings Per Share Diluted | -0.05 | -0.17 | -0.09 | -0.02 | -0.07 | -0.02 |
| Weighted Average Shares Outstanding | 722.54 Million | 233.19 Million | 204.41 Million | 120.68 Million | 120.43 Million | 119.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 722.54 Million | 233.19 Million | 204.41 Million | 120.68 Million | 120.43 Million | 119.85 Million |
| Gross Margin | 0.31 | 0.45 | 0.35 | 0.87 | 0.33 | 0.97 |
| EBIT Margin | -2.31 | -5.06 | -11.42 | 0.08 | -8.90 | -0.23 |
| Profit Margin | -2.54 | -9.05 | -12.73 | -0.25 | -12.24 | -0.15 |
| EBITDA | -30.28 Million | -37.39 Million | -17.35 Million | 820 Thousand | -6.39 Million | -2.76 Million |
| Earnings Before Tax Margin | -2.39 | -5.75 | -13.13 | -0.18 | -12.57 | -0.43 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 9.59 Million | 10.52 Million | 6.98 Million | 3.51 Million | 4.46 Million | 2.43 Million |
| Cost of Revenue | 5.27 Million | 8.14 Million | 6 Million | 2.09 Million | 2.47 Million | 2.86 Million |
| Gross Profit | 4.31 Million | 2.37 Million | 982.43 Thousand | 1.42 Million | 1.99 Million | -428 Thousand |
| Operating Expenses | 15.47 Million | 31.13 Million | 16.84 Million | 14.26 Million | 27.7 Million | 14.25 Million |
| Selling, General and Administrative Expenses | 14.87 Million | - | 15.74 Million | 13.91 Million | - | 14.2 Million |
| Research and Development Expenses | 594.56 Thousand | - | 1.09 Million | 351.93 Thousand | - | 52 Thousand |
| Other Expenses | - | - | - | - | -700 Thousand | - |
| Cost and Expenses | 20.74 Million | 39.28 Million | 22.84 Million | 16.35 Million | 30.17 Million | 17.11 Million |
| Operating Income | -11.15 Million | -28.75 Million | -15.86 Million | -12.84 Million | -25.7 Million | -14.68 Million |
| Interest Expense | 1.28 Million | 1.25 Million | 785.3 Thousand | 468.7 Thousand | 389 Thousand | 389 Thousand |
| Income Tax Expense | -1581.30 | 738.5 Thousand | 84.59 Thousand | 658.46 Thousand | 362 Thousand | 8000.00 |
| Earnings before Tax | -12.23 Million | -26.04 Million | -16.42 Million | -9.56 Million | -40.08 Million | -28.65 Million |
| Net Income | -12.23 Million | -26.78 Million | -16.51 Million | -10.22 Million | -40.44 Million | -28.66 Million |
| Earnings Per Share Basic | -0.02 | - | -0.02 | -0.01 | - | -0.11 |
| Earnings Per Share Diluted | -0.02 | - | -0.02 | -0.01 | - | -0.11 |
| Weighted Average Shares Outstanding | 782.05 Million | 722.54 Million | 742.19 Million | 702.9 Million | 233.19 Million | 250.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 782.05 Million | 722.54 Million | 742.19 Million | 702.9 Million | 233.19 Million | 250.37 Million |
| Gross Margin | 0.45 | 0.23 | 0.14 | 0.40 | 0.45 | -0.18 |
| EBIT Margin | -1.11 | - | -2.21 | -3.53 | - | -5.50 |
| Profit Margin | -1.28 | -2.54 | -2.36 | -2.91 | -9.05 | -11.77 |
| EBITDA | -10.68 Million | - | -15.42 Million | -12.41 Million | - | -13.4 Million |
| Earnings Before Tax Margin | -1.16 | -2.73 | -2.27 | -3.65 | -5.75 | -6.03 |
6091
QUCOF
1408
SPTJF
AMLH
SYSTMTXC